SEMA4B-211aa inhibits the production of phosphatidylinositol 3,4,5-trisphosphate by binding to p85, thus inhibiting the phosphorylation of protein kinase B (AKT) (Thr308), and ultimately inhibiting the progression of breast cancer 145. Here, AKT1 is linked to breast carcinoma.